Cite
HARVARD Citation
Elborn, J. et al. (2017). Phase I Studies of Acebilustat: Biomarker Response and Safety in Patients with Cystic Fibrosis. Clinical and translational science. 10 (1), pp. 28-34. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Elborn, J. et al. (2017). Phase I Studies of Acebilustat: Biomarker Response and Safety in Patients with Cystic Fibrosis. Clinical and translational science. 10 (1), pp. 28-34. [Online].